Kolarova H et al., 2026-02-04: Study combining in-vitro work with a 20-volunteer pilot finding significant S. aureus log reductions on skin after methylene blue photodynamic (and sonodynamic) treatment, about 2.4 log at best. The only human data located for the antibacterial claim, and it is a healthy-volunteer skin study.
In vivo, both MB-PDT and PDT+SDT achieved significant bacterial log reductions compared with baseline (p < 0.0001), with the highest efficacy observed under repeated irradiation plus SDT.
Kolarova H et al., 2026-02-04: Study combining in-vitro work with a 20-volunteer pilot finding significant S. aureus log reductions on skin after methylene blue photodynamic (and sonodynamic) treatment, about 2.4 log at best. The only human data located for the antibacterial claim, and it is a healthy-volunteer skin study. Study type: in vitro assays plus a pilot clinical study in 20 healthy volunteers. Country: Czech Republic (Charles University, Hradec Kralove). MB-PDT; repeated irradiation 2 x 30 J/cm2; ultrasound 1 MHz, 1 W/cm2; wavelength not stated in abstract. Funding/conflicts: none stated in record. Comparator: baseline/untreated skin. Best human evidence is a 2.4 log reduction, not 99.9%. Study type: uncontrolled series.
